Supportive Care

Treatment for Acute hepatitis E

Typical Dosage: Not applicable

Effectiveness
80%
Safety Score
95%
Clinical Trials
5,000
Participants
1M

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
95
DangerousModerateSafe
Treatment Details
Dosage Range
Not applicable
Time to Effect
2-4 weeks
Treatment Duration
Weeks to months (until recovery)
Evidence Quality
HIGH
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$450
Side Effect Mgmt:$100
Total Annual:$550
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0
Outcome-Based Costs
Cost per Responder
$561.22
Cost per Remission
$561.22
Supportive Care Outcomes

for Acute hepatitis E

Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+98%
Remission Rate
+98%

Sources:

nih.gov
bmj.com
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

FIX IT
Active Clinical Trials
1 active trial recruiting for Supportive Care in Acute hepatitis E

Comparative Evaluation of Oral Ursodeoxycholic Acid in Reducing Bilirubin Levels Among Patients With Acute Viral Hepatitis

NCT07525401NOT YET RECRUITINGNA
View Study
88 participants
INTERVENTIONAL
Started: Apr 1, 2026